Business Type
Biotechnology Enterprise
Visual supplier profile
Vianderma Biotech Co. Limited
Specializing in research, production, and sale of aesthetic medical products, this Shijiazhuang, China based company operates a GMP aseptic plant with CE approval and patented innovations for occidental markets.
Product Gallery
Primary Focus
Aesthetic Medical Products, Dermal Fillers, Botulinum Toxin
Established
2018
Employees
51 to 200
Annual Revenue
$10M to $50M
Certifications
About This Company
Biotechnology enterprise specialized in the research, production and sale of aesthetic medical products. The establishment of a professional technical team, GMP aseptic production plant, complete and strict testing system guarantee that we can continue to innovate and develop new products.
With CE approval and multiple patent certifications, our products are sold to occident market and received the admiration from consumers. In 2017, our factory introduced the most advanced production equipment from Germany. The scale of production has expanded again.
Location
Suppliers
China
Sincoheren Science And Technology Development
Manufacturers of medical and aesthetic equipment. Sincoheren have its own Research & Development department, Factory, Quality Control Depart
China
Beijing Mega Beauty Technology Co.,Ltd
Manufactures medical beauty equipment for hair removal, tattoo removal, skin rejuvenation, body contouring, lifting, and facial care. Its pr
Poland
Mustaf Medical
Mustaf Medical manufactures disposable medical supplies and cosmetics designed for single use applications. The company produces sanitary pr
United Kingdom
Green Med Limited
Green Med operates at the intersection of biomedical expertise and practical healthcare solutions, offering point of care testing services a
Australia
MAC Surgical
This leading orthopedic surgical instrument manufacturer specializes in precision medical device design and contract manufacturing services
Articles
Top 5 Companies in Health and Medical Industry
The global health and medical sector is shaped by a handful of companies whose scale, research capacity, and product diversity influence nea
Canadian Pharma Capacity Shifts That Change Import Timing
Canada's pharmaceutical manufacturing sector entered 2026 with a utilization rate near 78%, up roughly four points from two years earlier. T
From Overwhelmed Systems to Smarter Care: A Turning Point for Health Care
It no longer takes a crisis to reveal the pressure points in modern health care, they are visible in everyday experiences. Long wait times,
Direct to Consumer Pharmaceuticals
Direct to consumer pharmaceutical models are reshaping how patients access treatment, offering a more streamlined path between manufacturers
Digital Health and Telemedicine
The past few years have pushed digital health from the margins into the center of everyday care. What began as a workaround for distance and
Videos
French Biotech Turns Fecal Bacteria Into a Cancer Drug
This video looks at how a French biotech firm is developing a cancer care drug based on bacteria from human feces, and why the microbiome ha
Barrière's Vitamin Patch Innovation: A New Era in Supplements
Discover how Barrière, a leading vitamin patch brand, plans to disrupt the supplement industry as it projects doubling its revenue to $10 mi
Cancer Drugs Are Being Approved Before They Work
Pharmaceutical companies have made billions from cancer drugs that were never proven to actually help patients live longer. That is not a co
Why Gen Z Is Turning to Thorne for Wellness Solutions
Thorne has quietly become one of Gen Z’s favorite wellness brands by leaning into trust, quality, and a more thoughtful approach to suppleme
Medical Robots Are Expanding With Advances in Technology
As populations continue to grow older, healthcare systems are increasingly turning to robots across many different medical fields. Progress